Historical HPLC Evidence of Elevated Urinary Tyrosyl-Arginine and a Hypothesis Linking Dipeptide Metabolism to NR4A2 Dysfunction

This work documents historical high-performance liquid chromatography (HPLC) evidence of markedly elevated urinary tyrosyl-arginine (Tyr-Arg, kyotorphin) and presents a novel hypothesis linking dipeptide metabolism, monoaminergic pathways, and NR4A2 (NURR1) dysfunction. The analysis integrates a rare historical dataset generated by Dr. C. Everett L. Cade with modern understanding of dopaminergic regulation, mitochondrial stress, neuroinflammation, and neurodevelopmental disorder mechanisms associated with NR4A2-related syndrome. The manuscript is hypothesis-generating and intended to establish a permanent public scientific record, timestamp the first proposed link between elevated urinary Tyr-Arg and NR4A2 variants, encourage independent replication, and invite multidisciplinary collaboration across metabolomics, neurogenetics, neurochemistry, rare disease research, and pediatrics. Relevant keywords include: NR4A2, NURR1, NR4A2-related syndrome, dipeptide metabolism, Tyr-Arg, tyrosyl-arginine, kyotorphin, dopamine pathway dysfunction, HPLC urine analysis, rare disease metabolomics, Dr. Cade, Gatorade research, monoamine regulation, dopaminergic neuron development, mitochondrial dysfunction, neuroinflammation, neurodevelopmental disorders, personalized medicine. All referenced data are historical and fully de-identified, originally produced more than two decades ago. No new human or animal experiments were performed for this work.